Did not become law. It stopped in the House of Representatives's General Law Committee on February 20, 2003. The 2003 session has ended.
2003 Regular Session
House Bill 6273
AN ACT REQUIRING DRUG COMPANIES AND DRUG COMPANY REPRESENTATIVES TO DISCLOSE INCENTIVES PROVIDED TO HEALTH CARE PROVIDERS.
What it does
The synopsis the General Assembly published with the bill.
To protect patients and the general public by requiring drug companies and drug company representatives to disclose incentives provided to healthcare providers.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the House of Representatives
Sponsor
Its course
January 28 to February 20, 2003, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action2 actions on 2 days
In the House of RepresentativesJan 28 to Feb 20 · stopped23 days
General Law CommitteeJan 28 to Feb 20 · stopped23 days
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.
In the House of Representatives Jan 28 – Feb 20
- Jan 28Introduced and sent to General Law Committee
- Feb 20Merged into HB 6473
All 2 actions, as published
- Jan 28REF. TO JOINT COMM. ONBoth houses
- Feb 20Merged intoBoth houses